Internal Medicine Alert – February 15, 2008
February 15, 2008
View Issues
-
Diagnosing UTI is as Simple as 1, 2, 3
Three criteria identify women who would benefit from empiric antibiotics for cystitis. -
The Long-term Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism
Patients with a first VTE event occurring in association with a reversible or time-limited risk factor should be treated with anticoagulants for at least three months, whereas patients with a first PE should be treated for at least six to 12 months; in fact, a case can be made for indefinite anticoagulant therapy in PE patients who have a great concern about recurrent PE and/or who are minimally concerned about the bleeding risk of anticoagulant therapy and the need for frequent determinations of the INR. -
Special Feature: Female Physicians at Greater Risk for Suicide
Female physicians have more than twice the rate of suicide as other professional women and are proportionally at greater risk compared with their male physician counterparts. -
Nebivolol Tablets (Bystolic™)
The FDA has approved another beta-adrenergic blocker. -
Clinical Briefs by Louis Kuritzky, MD
Testosterone in Older Men: Is Low Normal Too Low?, CT Pulmonary Angiography as Good as Ventilation- perfusion Scanning for Suspected Pulmonary Embolus, Vertebral Fracture Begets Vertebral Fractureand -
ECG Review: Chest Pain After Bypass
The 12-lead ECG and lead II rhythm strip in the Figure were obtained from a 59-year old man several days after coronary bypass. He complained of postitional chest pain. How would you interpret his ECG given this clinical context? -
Pharmacology Watch
Rosiglitazone (Avandia) implicated in yet another study; Prilosec and Nexium not associated with cardiac events; Anastrozole (Arimidex) shown more effective than tamoxifen for treatment of early-stage breast cancer; antibiotics show no effect on sinusitis; FDA actions.